» Articles » PMID: 23044674

Venous Thromboembolism After Surgery for Inflammatory Bowel Disease: Are There Modifiable Risk Factors? Data from ACS NSQIP

Overview
Specialty Gastroenterology
Date 2012 Oct 10
PMID 23044674
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although it is commonly reported that IBD patients are at increased risk for venous thromboembolic events, little real-world data exist regarding their postoperative incidence and related outcomes in everyday practice.

Objective: We aimed to identify the rate of venous thromboembolism and modifiable risk factors within a large cohort of surgical IBD patients.

Design: We performed a retrospective review of IBD patients who underwent colorectal procedures.

Patients: Patient data were obtained from the American College of Surgeons National Surgical Quality Improvement Program 2004 to 2010 Participant Use Data Files.

Main Outcome Measures: The primary outcomes measured were short-term (30-day) postoperative venous thromboembolism (deep vein thrombosis and pulmonary embolism). Clinical variables were analyzed by univariate and multivariate analyses to identify modifiable risk factors for these events.

Results: A total of 10,431 operations were for Crohn's disease (52.1%) or ulcerative colitis (47.9%), and 242 (2.3%) venous thromboembolic events occurred (178 deep vein thromboses, 46 pulmonary embolisms, 18 both) for a combined rate of 1.4% in Crohn's disease and 3.3% in ulcerative colitis. Deep vein thrombosis and pulmonary embolism each occurred at a mean of 10.8 days postoperatively (range for each, 0-30 days). A multivariate model found that bleeding disorder, steroid use, anesthesia time, emergency surgery, hematocrit <37%,malnutrition, and functional status were potentially modifiable risk factors that remained associated (p < 0.05) with venous thromboembolism on regression analysis. Patients with thromboembolism had longer length of stay (18.8 vs 8.9 days), more complications (41% vs 18%), and a higher risk of death (4% vs 0.9%).

Limitations: This study was limited by its retrospective design and its limited generalizability to nonparticipating hospitals.

Conclusions: Inflammatory bowel disease patients are at increased risk for postoperative venous thromboembolism. Reducing preoperative anemia, steroid use, malnutrition, and anesthesia time may also reduce venous thromboembolism in this at-risk population. Risk-reducing, preventative strategies are needed in this at-risk population.

Citing Articles

Prevalence of Malnutrition and Micronutrient Deficiencies in Older Adults with Ulcerative Colitis.

Memel Z, Thiemann A, Dort C, Mahadevan U, Beck K Dig Dis Sci. 2024; 69(11):4203-4213.

PMID: 39438412 DOI: 10.1007/s10620-024-08650-z.


Comparison of Post-Operative Outcomes of Right Colectomy between Crohn's Disease and Adenocarcinoma of the Right Colon: A Retrospective Cohort Study.

Bursztyn N, Slomowitz E, Assaf D, Yahia E, Kent I, Wasserberg N J Clin Med. 2024; 13(10).

PMID: 38792351 PMC: 11122225. DOI: 10.3390/jcm13102809.


Peri-Operative Optimization of Patients with Crohn's Disease.

Syed H, Nadeem A, Gardinier D, Weekley K, Ribakow D, Lupe S Curr Gastroenterol Rep. 2024; 26(5):125-136.

PMID: 38421577 PMC: 11081987. DOI: 10.1007/s11894-024-00925-9.


Standard and Extended Thromboprophylaxis in Patients with Inflammatory Bowel Disease: A Literature Review.

Harindranath S, Varghese J, Afzalpurkar S, Giri S Euroasian J Hepatogastroenterol. 2024; 13(2):133-141.

PMID: 38222957 PMC: 10785145. DOI: 10.5005/jp-journals-10018-1401.


Preoperative laboratory parameters associated with deep vein thrombosis in patients with ovarian cancer: retrospective analysis of 3,147 patients in a single institute.

Shim H, Lee Y, Kim J, Lim M, Lee D, Park S J Gynecol Oncol. 2024; 35(4):e38.

PMID: 38216136 PMC: 11262889. DOI: 10.3802/jgo.2024.35.e38.


References
1.
Dobesh P, Wittkowsky A, Stacy Z, Dager W, Haines S, Lopez L . Key articles and guidelines for the prevention of venous thromboembolism. Pharmacotherapy. 2009; 29(4):410-58. DOI: 10.1592/phco.29.4.410. View

2.
Murthy S, Nguyen G . Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol. 2011; 106(4):713-8. DOI: 10.1038/ajg.2011.53. View

3.
Holubar S, Larson D, Dozois E, Pattana-Arun J, Pemberton J, Cima R . Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach?. Dis Colon Rectum. 2009; 52(2):187-92. DOI: 10.1007/DCR.0b013e31819a5cc1. View

4.
Kulnigg-Dabsch S, Evstatiev R, Dejaco C, Gasche C . Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia. PLoS One. 2012; 7(4):e34520. PMC: 3323537. DOI: 10.1371/journal.pone.0034520. View

5.
Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M . Inflammation and coagulation in inflammatory bowel disease: The clot thickens. Am J Gastroenterol. 2006; 102(1):174-86. DOI: 10.1111/j.1572-0241.2006.00943.x. View